Suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect by inhibiting histone deacetylation

被引：0
|
作者：
Reddy, P
Maeda, Y
Hotary, K
Dinarello, CA
Ferrara, JL
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Colorado, Med Ctr, Denver, CO 80202 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2004年 / 10卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2003.12.061
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
29
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
    Huang, Ying
    Zou, Yujing
    Jiao, Yiqun
    Shi, Peijie
    Nie, Xiaoli
    Huang, Wei
    Xiong, Chuanfeng
    Choi, Michael
    Huang, Charles
    Macintyre, Andrew N.
    Nichols, Amanda
    Li, Fang
    Li, Chuan-Yuan
    MacIver, Nancie J.
    Cardona, Diana M.
    Brennan, Todd, V
    Li, Zhiguo
    Chao, Nelson J.
    Rathmell, Jeffrey C.
    Chen, Benny J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect
    Clouthier, SG
    Cooke, KR
    Teshima, T
    Lowler, KP
    Liu, C
    Connolly, K
    Ferrara, JLM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (09) : 592 - 603
  • [43] T-CELL DEPLETION OF HLA AND HAPLOIDENTICAL MARROW REDUCES GRAFT-VERSUS-HOST DISEASE BUT IT MAY IMPAIR A GRAFT-VERSUS-LEUKEMIA EFFECT
    HENSLEE, PJ
    THOMPSON, JS
    ROMOND, EH
    DOUKAS, MA
    METCALFE, M
    MARSHALL, ME
    MACDONALD, JS
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 2701 - 2706
  • [44] New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects
    Deeg, HJ
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (01) : 15 - 21
  • [45] New Strategies for Prevention and Treatment of Graft-versus-Host Disease and for Induction of Graft-versus-Leukemia Effects
    H. Joachim Deeg
    International Journal of Hematology, 2003, 77 : 15 - 21
  • [46] Role of tumor necrosis factor-α in graft-versus-host disease and graft-versus-leukemia responses
    Korngold, R
    Marini, JC
    de Baca, ME
    Murphy, GF
    Giles-Komar, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (05) : 292 - 303
  • [47] Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects
    Reddy, P
    Teshima, T
    Hildebrandt, G
    Williams, DL
    Liu, C
    Cooke, KR
    Ferrara, JLM
    BLOOD, 2003, 101 (07) : 2877 - 2885
  • [48] Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease
    Krijanovski, OI
    Hill, GR
    Cooke, KR
    Teshima, T
    Crawford, JM
    Brinson, YS
    Ferrara, JLM
    BLOOD, 1999, 94 (02) : 825 - 831
  • [49] Graft-versus-Host Disease, the Graft-versus-Leukemia Effect, and Mixed Chimerism following Nonmyeloablative Stem Cell Transplantation
    Shimon Slavin
    International Journal of Hematology, 2003, 78 : 195 - 207
  • [50] Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation
    Slavin, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 195 - 207
12345